)
)
Duearity Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Duearity
Access all reports
Duearity AB is a Swedish medical technology company specializing in innovative solutions for tinnitus treatment. The company's primary product, Tinearity G1, is a medical device designed to alleviate tinnitus symptoms through a non-invasive method that uses white noise delivered via the skull bone, bypassing the ear canal. This approach is based on Tinnitus Retraining Therapy, which has been used clinically for several decades. The company is headquartered in Malmö, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
DEAR
Country
🇸🇪 Sweden